Clinical trial

Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.

NCT01310894

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-02-01

PhasePHASE3

Study timeline

Study start (unknown)2011-02-01Date precision: month

Registry last updated2019-07-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

TOOKAD® SolubleDRUG

Sponsors & collaborators

Steba Biotech S.A.lead sponsor

Mapped research locations

BarcelonaSpain3 ParisFrance3 LondonUnited Kingdom2 MadridSpain1 HamburgGermany1 ValenciaSpain1 ToulouseFrance1 SevilleSpain1 MarseilleFrance1 LilleFrance1 RomaItaly1 LeuvenBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01310894 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.